Gene expression analysis during tumor enhancement by the dietary phytochemical, 3,3'-diindolylmethane, in rainbow trout.
Indole-3-carbinol (I3C) and 3,3'-diindolylmethane (DIM), a primary I3C derivative, are known dietary chemopreventive agents also available as supplements. However, I3C has been found to act as a tumor promoter in rat (multi-organ) and trout (liver) models. I3C and DIM were previously found to be estrogenic in trout liver based on toxicogenomic profiles. In this study, we compare the post-initiation effects of DIM and 17beta-estradiol (E2) on aflatoxin B(1) (AFB(1))-induced hepatocarcinogenesis in trout. Trout were initiated as embryos with AFB(1) and juvenile fish were fed diets containing 0, 120 or 400 p.p.m. DIM or 5 p.p.m. E2 for 18 weeks. Tumor incidence was determined at 13 months and found to be significantly elevated in AFB(1)-initiated trout fed either 400 p.p.m. DIM or 5 p.p.m. E2 compared with control animals. To evaluate the mechanism of tumor enhancement, hepatic gene expression profiles were examined in animals fed promotional diets during the course of tumorigenesis and in hepatocellular carcinomas (HCCs) of initiated animals. We demonstrate that DIM alters gene expression profiles similar to E2 in liver samples during tumorigenesis and in HCC tumors. Further, HCCs from animals on DIM and E2 promotional diets had a transcriptional signature indicating decreased invasive or metastatic potential compared with HCCs from control animals. Overall, these findings are the first to demonstrate tumor promotion by DIM. They confirm the importance of estrogenic signaling in the mechanism of promotion by dietary indoles in trout liver and indicate a possible dual effect that enhances tumor incidence and decreases potential for metastasis.
Tilton
Susan C
SC
Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA.
Hendricks
Jerry D
JD
Orner
Gayle A
GA
Pereira
Cliff B
CB
Bailey
George S
GS
Williams
David E
DE
D016604:Aflatoxin B1; D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced / Q000378:metabolism*; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced / Q000378:metabolism; D019587:Dietary Supplements; D004958:Estradiol / Q000494:pharmacology; D020869:Gene Expression Profiling; D007211:Indoles / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008113:Liver Neoplasms / Q000139:chemically induced / Q000378:metabolism*; D020411:Oligonucleotide Array Sequence Analysis; D017686:Oncorhynchus mykiss; D028321:Plant Preparations / Q000494:pharmacology
D016588:Anticarcinogenic Agents; D007211:Indoles; D028321:Plant Preparations; D004958:Estradiol; D016604:Aflatoxin B1; C016392:3,3'-diindolylmethane